As the referendum-mandated departure of the United Kingdom (“Brexit”) from the European Union (EU) continues to unfold, international discourse surrounds the tradeoffs of EU membership, and whether European citizens perceive the benefits to be worth the costs.
What skills are the mostly demanded in certain area for certain industry? Does program match local market better than the national market for certain industry?
A manuscript for publication is under preparation currently.
How a rock music project’s characteristics are associated with success on kickstarter.com, where the predictor variables include characteristics related to project preparation, presentation, and the level of funding sought, as well as features extracted from sound samples of these projects?
Bhaduri, Moinak, Joe Dery, Dominique Haughton, Tao Li, Piaomu Liu, and Wenxiu Nan. "Dynamics of Reward‐Based Crowdfunding: Kickstarter Rock Music Projects." CHANCE 34, no. 1 (2021): 4-13.
During the COVID-19 pandemic, does the commonly used anti-hypertension medications (ACEI or ARB) safe to use, for Hypertension patients? Would the patients who use these medications are more risky on a severe situation when they got COVID-19?
Li M, Wang Y, Ndiwane N, Orner MB, Palacios N, Mittler B, Berlowitz D, Kazis LE, Xia W. The association of COVID-19 occurrence and severity with the use of angiotensin converting enzyme inhibitors or angiotensin-II receptor blockers in patients with hypertension. PloS one. 2021 Mar 18;16(3):e0248652.
What is the sustainability of antibodies targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)? It is essential for predicting immune response against the Coronavirus disease 2019 (COVID-19). This study is clinically important for the prediction of immune response capacity in COVID-19 patients.
Xia, W., Li, M., Wang, Y., Kazis, L.E., Berlo, K., Melikechi, N. and Chiklis, G.R., 2021. Longitudinal analysis of antibody decay in convalescent COVID-19 patients. Scientific reports, 11(1), pp.1-9.
Legislation currently before Congress is aimed at reducing drug prices to ensure that essential medicines are available and affordable to all Americans. Corresponding to a major concern about such legislation is that reducing drug prices would lead to reduced industry spending on research and development (R&D) and slow the pipeline of new products.
This dashboard enables you to model the impact of drug price reductions of 0-20% with differential allocation of cost reductions through phased clinical development.